SHARON WEBER: Open Payments
NPI 1528597291 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 32 payments from 12 companies in 2025. Trend: 2023 $582 · 2024 $686 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $198 |
| Boston Scientific Corporation | 1 | $138 |
| Novo Nordisk Inc | 5 | $97 |
| Madrigal Pharmaceuticals | 5 | $96 |
| Phathom Pharmaceuticals, Inc. | 5 | $76 |
| Lilly USA, LLC | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| QOL Medical, LLC | 1 | $25 |
Products named: Korlym, Axios, Wegovy, REZDIFFRA, VOQUEZNA, MOUNJARO, EOHILIA, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
